Garner, NC, United States of America

Myles Lindsay

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Grifols Therapeutics Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myles Lindsay. Retrieved from https://idiyas.com/inventor/myles-lindsay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Myles Lindsay: Innovator in Plasminogen Research

Introduction

Myles Lindsay is a notable inventor based in Garner, NC (US). He has made significant contributions to the field of biochemistry, particularly in the area of plasminogen research. His innovative work has led to the development of valuable methods and compositions that have potential applications in medical science.

Latest Patents

Myles Lindsay holds a patent for "Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom." This patent focuses on compositions and methods for preparing plasminogen, specifically recombinant plasminogen, and outlines methods for utilizing these compositions to prepare plasmin. His work in this area is crucial for advancing therapeutic applications.

Career Highlights

Myles is currently employed at Grifols Therapeutics Inc., where he continues to push the boundaries of research and innovation. His expertise in biochemistry and dedication to his work have positioned him as a key figure in his field.

Collaborations

Myles collaborates with talented professionals such as Edward Koepf and Kenya Stokes. These partnerships enhance the research environment and contribute to the success of their projects.

Conclusion

Myles Lindsay's contributions to plasminogen research exemplify the impact of innovation in the medical field. His patent and ongoing work at Grifols Therapeutics Inc. highlight his commitment to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…